These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1777214)

  • 41. Dopamine release in striatal slices of rats previously submitted to electroconvulsive shock.
    Passarelli F; Carmenini E; Calò L; Pontieri FE
    Brain Res; 1997 Nov; 774(1-2):239-41. PubMed ID: 9452217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of dopamine depletion upon the K(+)-evoked release of CCK from superfused striatal slices.
    Sierralta J; Gysling K
    Neurosci Lett; 1990 May; 112(2-3):313-7. PubMed ID: 2113658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of taurine, GABA and dopamine from rat striatal slices: mutual interactions and developmental aspects.
    Kontro P; Oja SS
    Neuroscience; 1988 Jan; 24(1):49-58. PubMed ID: 3368056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of N-ethylmaleimide on dopamine release in the rat striatum after repeated treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1994 May; 257(3):243-8. PubMed ID: 7916300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
    Heal DJ; Frankland AT; Gosden J; Hutchins LJ; Prow MR; Luscombe GP; Buckett WR
    Psychopharmacology (Berl); 1992; 107(2-3):303-9. PubMed ID: 1615130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
    Nash JF; Yamamoto BK
    Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices.
    Lillrank SM; Oja SS; Saransaari P; Seppälä T
    Int J Neurosci; 1991 Sep; 60(1-2):1-15. PubMed ID: 1685488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex.
    Stephans SE; Yamamoto BY
    Brain Res; 1995 Nov; 700(1-2):99-106. PubMed ID: 8624733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats.
    Cass WA; Manning MW; Dugan MT
    Neurosci Lett; 1998 Jun; 248(3):175-8. PubMed ID: 9654337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
    Ito C; Onodera K; Sakurai E; Sato M; Watanabe T
    J Pharmacol Exp Ther; 1996 Oct; 279(1):271-6. PubMed ID: 8859003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum.
    Nakayama M; Koyama T; Yamashita I
    Brain Res; 1993 Jan; 601(1-2):209-12. PubMed ID: 8431767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3H]Dopamine accumulation and release from striatal slices in young, mature and senescent rats.
    Thompson JM; Whitaker JR; Joseph JA
    Brain Res; 1981 Nov; 224(2):436-40. PubMed ID: 7284852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potassium markedly potentiates the effect of veratridine on dopamine release from rat superfused striatal ribbons.
    Olivier V; Miquet JM; Aubeneau M; Blanchard JC; Doble A; Boireau A
    J Pharm Pharmacol; 1992 Jan; 44(1):61-3. PubMed ID: 1350632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis.
    Yamamoto BK; Davy S
    J Neurochem; 1992 May; 58(5):1736-42. PubMed ID: 1348523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of fluorocitrate on transmitter amino acid release from rat striatal slices.
    Paulsen RE; Contestabile A; Villani L; Fonnum F
    Neurochem Res; 1988 Jul; 13(7):637-41. PubMed ID: 2901051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.